Cancer Reports (Oct 2022)

Co‐occurrence of JAK2 V617F‐mutated essential thrombocythemia and chronic lymphocytic leukemia harboring der(8;17)(q10;q10)

  • Masahiro Manabe,
  • Nao Tanizawa,
  • Satoru Nanno,
  • Yuuji Hagiwara,
  • Reiko Asada,
  • Ki‐Ryang Koh

DOI
https://doi.org/10.1002/cnr2.1658
Journal volume & issue
Vol. 5, no. 10
pp. n/a – n/a

Abstract

Read online

Abstract Background and Case We herein present a case of the co‐occurrence of JAK2‐mutated essential thrombocythemia (ET) with chronic lymphocytic leukemia (CLL) harboring the recurrent and rare whole‐arm translocation, der(8;17)(q10;q10). The co‐existence of lymphoproliferative neoplasms and myeloproliferative neoplasms is suggested to be a rare event. Under this condition, the lymphoproliferative disorder presents a clinically indolent course with a low‐risk biological profile. However, the present case showed aggressive disease progression, reflecting a poor prognostic factor; that is, the loss of 17p caused by the whole‐arm der(8;17)(q10;q10) translocation. Conclusion The present case report emphasizes the importance of considering the involvement of a genetically poor prognostic factor, regardless of the co‐occurrence of CLL and ET.

Keywords